SCIOS INC.
🏢 View company profile →85Patents
2Active
85Granted
38Portfolio score
Filing activity: Feb 8, 1990 → Feb 27, 2008 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6277989A | Quinazoline derivatives as medicaments | Chemistry; Metallurgy | 132 | Expired |
| US6284727A | Prolonged delivery of peptides | Chemistry; Metallurgy | 120 | Expired |
| US6476031B1 | Quinazoline derivatives as medicaments | Chemistry; Metallurgy | 103 | Expired |
| US6184226A | Quinazoline derivatives as inhibitors of P-38 .alpha. | Chemistry; Metallurgy | 84 | Expired |
| US6187330A | Controlled release delivery of peptide or protein | Human Necessities | 75 | Expired |
| US5604293A | Recombinant human basic fibroblast growth factor | Human Necessities | 66 | Expired |
| US5962266A | Protease inhibitor peptides | Chemistry; Metallurgy | 51 | Expired |
| US6294359A | Human basic fibroblast growth factor analog | Chemistry; Metallurgy | 50 | Expired |
| US6130235A | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 50 | Expired |
| US6589954B1 | Compounds and methods to treat cardiac failure and other disorders | Chemistry; Metallurgy | 47 | Expired |
| US5948761A | Recombinant canine brain natriuretic peptide | Chemistry; Metallurgy | 43 | Expired |
| US6713276B2 | Modulation of A&bgr; levels by &bgr;-secretase BACE2 | Physics | 43 | Expired |
| US5912410A | Transgenic non-human mice displaying the amyloid-forming pathology of alzheimer's disease | Chemistry; Metallurgy | 41 | Expired |
| US6828303B2 | Prolonged delivery of peptides | Chemistry; Metallurgy | 40 | Expired |
| US6867209B1 | Indole-type derivatives as inhibitors of p38 kinase | Chemistry; Metallurgy | 37 | Expired |
| US7183070B2 | Inhibition of Aβ production by β-secretase BACE2 | Physics | 36 | Expired |
| US6124430A | Human brain natriuretic peptides | Emerging Cross-Sectional Technologies | 36 | Expired |
| US6331309A | Hydrogel compositions for the controlled release administration of growth factors | Human Necessities | 36 | Expired |
| US6709855B1 | Methods for detection and use of differentially expressed genes in disease states | Chemistry; Metallurgy | 35 | Expired |
| US6162902A | Human BNP-specific antibodies | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6541477B2 | Inhibitors of p38-a kinase | Chemistry; Metallurgy | 33 | Expired |
| US5674710A | Recombinant techniques for production of human brain natriuretic peptide | Chemistry; Metallurgy | 30 | Expired |
| US6263287A | Systems for the analysis of gene expression data | Physics | 29 | Expired |
| US6613890B2 | Protease inhibitor peptides | Chemistry; Metallurgy | 29 | Expired |
| US7223766B2 | Bi-cyclic pyrimidine inhibitors of TGFβ | Chemistry; Metallurgy | 25 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.